Skip to content

Clinical trials

Completed Immune System Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Status: Completed Country / region: Canada Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20102
20113
20121
20131
20151
20161
20172
20185
20201
20211
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Pfizer3
Eli Lilly and Company2
McMaster University2
Altair Therapeutics, Inc.1
Baxalta now part of Shire1
Boston Children's Hospital1
CRISPR Therapeutics AG1
EMD Serono1
Ellodi Pharmaceuticals, LP1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases26
Autoimmune Diseases12
Hypersensitivity8
Hypersensitivity, Immediate8
Skin Diseases5
Dermatitis, Atopic4
Eczema4
Genetic Diseases, Inborn4
Skin Diseases, Eczematous4
Asthma3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.